Congress Materials - Rheumatology Advanced Practice Providers (RhAPP 2026)
2026 Rheumatology Advanced Practice Providers | Sep 23-26 | Las Vegas, NV
Biomarker-Driven Insights to Clinical Response in DAHLIAS: a Nipocalimab Trial for Sjögren’s Disease
R. Hal Scofield, Hurley Li, Jacques-Eric Gottenberg, David Galbraith, Keying Ma, Lynn Tomsho, Chris Sisk, Melissa Petrick, Matthew J. Loza, Jonathan Hubbard, Kim Campbell, Dawn Waterworth, Sheng Gao, Carolyn Cuff, Steven Leonardo, Kathy Sivils
Clinically Relevant Anti-Vaccine and Virus Antibodies in Patients with Sjogren’s Disease Treated with Nipocalimab: Post-Hoc Analysis of the DAHLIAS Study
Faye Yu, Eugene Myshkin, Jonathan J. Hubbard, Kim Campbell, Matthew J. Loza, Bea Rivard, Dessislava Dimitrova, Carolyn Cuff, Sheng Gao
Nipocalimab for Warm Autoimmune Hemolytic Anemia: Results From the Phase 2/3 Randomized Double-Blind ENERGY Study
Bruno Fattizzo, Irina Murakhovskaya, Yasutaka Ueda, Doug Schlichting, Kristen Sweet, Michael Zelasky, Tegan Magsam, Jagriti Craig, Jocelyn Leu, Leona Ling, Sheryl Pease, Cathye Shu
Nipocalimab in SLE: First-in-Class Efficacy and Safety Results Demonstrating Proof of Concept for FcRn Blockade From the Phase 2 JASMINE-SLE Study
Richard A Furie, Ronald van Vollenhoven, Rafał Wojciechowski, Eric Morand, Guillermo J Pons-Estel, George A Karpouzas,6 Bart van Hartingsveldt, Robert W Hoffman, Terence Rooney, Sheng Gao, Robert Gordon, Kim Hung Lo, Bea Rivard, Jocelyn H Leu, Federico Zazzetti, Stanley J Marciniak, Steven Leonardo, Keying Ma, Kathy Sivils, Leonard Dragone, Loqmane Seridi, Linda Okonkwo, Erika Noss, Fang Liu-Walsh, Michelle Petri
Pregnancy outcomes in maternal exposure to guselkumab: Review of cases reported to the Company Global Safety Database
Uma Mahadevan, Millie Long, Mette Julsgaard, Connie Lin, Anja Geldhof, Mauricio Rosas Ballina, Hewei Li, Allison Hester, Javier P. Gisbert, María Chaparro
Structural Damage Progression and Clinical Response to Guselkumab in Participants With Active and Erosive Psoriatic Arthritis: Post hoc Analysis at Week 24 of the Phase 3b, Randomized, Double-blind, Placebo-controlled APEX Study
Christopher T Ritchlin, Proton Rahman, Laura C Coates, Alexa P Kollmeier, Yusang Jiang, Luis Calderon, Soumya D Chakravarty, Elizabeth Adamson, Karissa Lozenski, Arthur Kavanaugh, Philip J Mease
Copies of these presentations are for personal use only and may not be reproduced without written permission from the presentation author.
Connect with us
Connect with us
Would you like to clear and leave your conversation? Message history will be lost.